Interobserver Reliability Between Neurologists in Training of Parkinson's Disease Rating Scales
Movement Disorders 6:330-335, Geminiani,G.,et al, 1991
Neurological and Neuropsychiatric Spectrum of Wilson's Disease:A Prospective Study of 45 Cases
J Neurol 238:281-287, Oder,W.,et al, 1991
United Parkinson Foundation Neurotransplantation Registry on Adrenal Medullary Transplants:Presurg, & 1-and 2-yr Follow-up
Neurol 41:1719-1722, Goetz,C.G.,et al, 1991
Challenge Tests to Predict the Dopaminergic Response in Untreated Parkinson's Disease
Neurol 41:1723-1725, Highes,A.J.,et al, 1991
The Apomorphine Test in Parkinsonian Syndromes
JNNP 54:870-872, D'Costa,D.F.,et al, 1991
A Multi-Center, Double-Blind Study on Slow-Release Bromocriptine in the Treatment of Parkinson's Disease
Neurol 41:1598-1602, Mannen,T.,et al, 1991
Pleuropulmonary Disease Associated with Dopamine Agonist Therapy
Ann Neurol 30:613-616, Bhatt,M.H.,et al, 1991
Parkinsonism and Defects of Praxis Following Methanol Poisoning
JNNP 54:843-844, Mozaz,M.J.,et al, 1991
Autonomic Nervous Function in Progressive Supranuclear Palsy
Arch Neurol 48:1083-1084, vanDijk,J.G.,et al, 1991
Dopa-responsive Dystonia:[18F]Dopa Positron Emission Tomography
Ann Neurol 30:24-30, Sawle,G.V.,et al, 1991
Driving in Parkinson's Disease
Neurol 41:517-520, Dubinsky,R.M.,et al, 1991
The Phenotype of the X-Linked Dystonia-Parkinsonism Syndrome, An Assessment of 42 Cases in the Philippines
Medicine 70:179-187, Lee,J.V.,et al, 1991
Preclinical Detection of Parkinson's Disease
Neurology Suppl 2, 41:5-921991., Koller,W.C.&Langston,J.W., 1991
Occurrence of Resting Tremor in Parkinson's Disease
Neurol 41:1298-1299, Rajput,A.H.,et al, 1991
N-Methyl-D-Aspartate Antagonists in the Treatment of Parkinson's Disease
Arch Neurol 48:977-981, Greenamyre,J.T.&O'Brien,C.F., 1991
Mitochondrial Oxidative Phosphorylation Defects in Parkinson's Disease
Ann Neurol 30:332-339, 3301991., Shoffner,J.M.,et al, 1991
Neuroleptic Malignant Synd in Parkinson's after Withdrawal or Alteration of Dopaminergic Therapy
Arch Int Med 151:794-796, Keyser,D.L.&Rodnitzky,R.L., 1991
The Epidemiology of Parkinson's Disease, A Case-Control Study of Young-Onset and Old-Onset Patients
Arch Neurol 48:903-907, Stern,M.,et al, 1991
Implantation of Human Fetal Ventral Mesencephalon to the Right Caudate Nucleus in Advanced Parkinson's Disease
Arch Neurol 48:822-827, Henderson,B.T.H.,et al, 1991
Stereotaxic Implantation of Autologous Adrenal Medulla Into Caudate Nucleus in Parkinsonism, One-Year Follow-up
Arch Neurol 48:813-820, Fazzini,E.,et al, 1991
Complex Visual Hallucinations and Cyclosporine Neurotixicity
Neurol 41:1156, Steg,R.E.&Garcia,E.G., 1991
Literary Neurologic Syndromes, Alice in Wonderland
Arch Neurol 48:649-651, Rolak,L.A., 1991
Young-Onset Parkinson's Disease:A Clinical Review
Neurol 41:168-173, Golbe,L.I., 1991
Erythropoeitin and Visual Hallucinations
NEJM 325:285, Steinberg,H., 1991
Stereotactic Ventrolateralis Thalamotomy for Refractory Tremor in Post-Levodopa Era Parkinson's Dis
J Neurosurg 75:723-730, Fox,M.W.,et al, 1991
Does Ageing Aggravate Parkinsonisn Disability?
JNNP 54:780-782, Blin,J.,et al, 1991
Clozapine is Beneficial for Psychosis in Parkinson's Disease
NEurol 41:1699-1700, Kahn,N.,et al, 1991
Effects of Head Trauma from Motor Vehicle Accidents on Parkinson's Disease
Ann Neurol 29:191-193, Goetz,C.G.&Stebbins,G.T., 1991
Clinicopath Conf
Cerebral Amyloid Angiopathy, Case 27-1991, NEJM 325:42-54991., , 1991
Idazoxan Treatment in Progressive Supranuclear Palsy
Neurol 41:986-991, Ghika,J.,et al, 1991
Positron Emission Tomography in Progressive Supranuclear Palsy
Arch Neurol 48:389-391, Bhatt,M.H.,et al, 1991
Presynaptic Parkinsonism in Olivopontocerebellar Atrophy:Clinical, pathological, and Neurochemical Evidence
Ann Neurol 30:425-428, Pascual,J.,et al, 1991
Frontal Lobe Degeneration:Clinical, Neuropsychologicaland SPECT Characteristics
Neurol 41:1374-1382, Miller,B.L.,et al, 1991
Essential Tremor:Clinical Correlates in 350 Patients
Neurol 41:234-238, Lou,J.&Jankovic,J., 1991
Long-Term Suppression of Tremor by Chronic Stimulation of the Ventral Intermediate Thalamic Nucleus
Lancet 337:403-406, Benabid,A.L.,et al, 1991
Withdrawal of Life-Support from Patients in a Persistent Vegetative State
Lancet 337:96-98, Boyd,K.M., 1991
Dopa-Responsive Dystonia:Long-Term Treatment Response and Prognosis
Neurol 41:174-181, Nygaard,T.G.,et al, 1991
Environmental Risk Factors in Siblings with Parkinson's Disease
Arch Neurol 48:287-289, Wong,G.F.,et al, 1991
Early Combination of Selegiline and Low-Dose Levodopa as Initial Symptomatic Therapy in Parkinson's Dis
Arch Neurol 48:31-34, Elizan,T.S.,et al, 1991
The Nigrostriatal Dopaminergic System Assessed in Vivo by PET Volunteers & Pts with Parkinson's Disease
Arch Neurol 47:1290-1298, Leenders,K.L.,et al, 1990
Variable Expression of Parkinson's Disease:A Base-line Analysis of the DATATOP Cohort
Neurol 40:1529-1534, Jankovic,J.,et al, 1990
Fetal Homotransplants (Ventral Mesencephalon & Adrenal Tissue) to the Striatum of Parkinsonian Subjects
Arch Neurol 47:1281-1285, Madrazo,I.,et al, 1990
Autologous Transplantation of Adrenal Medulla in Parkinson's Disease, 18-Mo Results
Arch Neurol 47:1286-1289, Olanow,C.W.,et al, 1990
Stroke and Its Modification in Parkinson's Disease
Stroke 21:1395-1399, Struck,L.K.,et al, 1990
Driving and Parkinson's Disease
Editorial, Lancet 336:7811990., , 1990
A Comparison of Effects of Controlled-Release Levodopa (Madopar CR) with Levodopa in Late Parkinson's Disease
JNNP 53:220-223, MacMahon,D.G.,et al, 1990
Peduncular Hallucinosis Associated with Isolated Infarction of the Substantia Nigra Pars Reticulata
Ann Neurol 27:500-504, McKee,A.C.,et al, 1990
Neurologic Manifestations of Giant Cell Arteritis
Am J Med 89:67-72, Reich,K.A.,et al, 1990
PET Study in Progressive Supranuclear Palsy, Hypometabolic Pattern
Arch Neurol 47:747-752, Blin,J.,et al, 1990
Cortical-Basal Ganglionic Degeneration
Neurol 40:1203-1212, Riley,D.E.,et al, 1990